The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C

Journal Title: One Health & Risk Management - Year 2020, Vol 1, Issue 1

Abstract

Introduction. Viral hepatitis C (HCV) is a significant global health problem. The risk of developing chronic HCV is up to 80% of patients, of whom 10-20% can develop liver cirrhosis or hepatocellular carcinoma which can lead to death. Treatment with direct-acting antiviral agents (DAAs) contributes to a sustained virological response (SVR) in 97-99% of cases. Material and methods. The study was conducted on 206 patients with chronic HCV who underwent two generic antiviral agent therapies: group I (103) – Sofosbuvir 400 mg + Ledipasvir 80 mg, whereas group II (103) – Sofosbuvir 400 mg + Daclatasvir 60 mg orally, once a day, for 12 weeks. The assessment of hepatitis C virus RNA and genotype, as well as the degree of hepatic fibrosis by Fibroscan, biochemical and complete blood count (CBC) indices were carried out. Results. The study results showed high efficacy of the generic DAAs treatment in patients with chronic HCV over 12 weeks. The SVR rate made up 90.3% in Sofosbuvir + Ledipasvir therapy and 86.4% – in Sofosbuvir + Daclatasvir. Similar treatment response was recorded in naive patients and those who previously underwent unsuccessful treatment with Pegylated Interferon and Ribavirin. The DAAs treatment showed the following minor adverse reactions: asthenia, headache, sleep dCiosncoclnutsiniounatsi.on. disorder, and nausea, which did not require treatment The 12-week course of DAAs therapy exhibited high SVR rate in both chronic HCV naive patients and those previously treated with Pegylated Interferon and Ribavirin.

Authors and Affiliations

Irina RUSU*, Liliana HODOROGEA, Tiberiu HOLBAN

Keywords

Related Articles

Study of antibiotic susceptibility of Salmonella spp. isolated from food and biological material

Introduction. Antimicrobial resistance is a global public health problem that the world is facing today. Material and methods. Isolation and identification of Salmonella spp. were performed according to DSTU EN 12824:...

Physical development and eating habits of a group of teenagers from Dimitrie Cantemir high school in Iasi

Introduction. Eating habits are formed in the first years of life and sometimes persist throughout lifetime. It is necessary to develop coherent nutritional educational programs to guide adolescents towards a healthy die...

Acute flaccid paralysis in children in the post certification period of the Republic of Moldova as a country free of wild poliomyelitis

Introduction. Monitoring acute flaccid paralysis (AFP) is a key strategy used by the Global Polio Eradication Initiative (GPEI) in assessing the progress towards the global eradication goal. Material and methods. A cros...

Challenging diagnosis: coexistence of two rare diseases - familial mediterranean fever and loyez-dietz syndrome type 3

Introduction. Autoinflammatory diseases are a group of genetically inherited disorders and familial Mediterranean fever is the most common of this group. It is rare in other than Middle East populations. Clinical manifes...

Viability and phenotypic heterogeneity of Rhodococcus Rhodochrous CNMN-AC-05 in the presence of fullerene C60

Introduction. In recent years, due to wide applications of nanotechnologies in various fields, the safety of nanomaterials has become a pressing issue. Fullerene C60 is not an exception. Research on the activity of micro...

Download PDF file
  • EP ID EP683644
  • DOI 10.5281/zenodo.3700945
  • Views 163
  • Downloads 0

How To Cite

Irina RUSU*, Liliana HODOROGEA, Tiberiu HOLBAN (2020). The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C. One Health & Risk Management, 1(1), -. https://europub.co.uk/articles/-A-683644